RICHMOND, Va.--(BUSINESS WIRE)--Commonwealth Biotechnologies, Inc. (“CBI”) (NASDAQ Capital Market: CBTE) is pleased to announce that the Senior Vice President and General Manager of Genzyme Pharmaceuticals, Mr. Daniel O. Hayden, has been appointed as a non-executive Director of CBI. Mr. Hayden has over 35 years experience in the pharmaceutical and biotechnology industries, the last 8 of which he has served in senior executive roles with Genzyme Pharmaceuticals, a business unit of Genzyme Corporation. Mr. Hayden has well documented achievements in global business management, strategic planning, new business development and strategic alliance partnering.
